Spain· ES:58-181-03C
INHIBACE PLUS 5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing cilazapril + hidroclorotiazida, registered in Spain by Cheplapharm Arzneimittel Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- cilazapril + hidroclorotiazida
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72680928EUR 16.24
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cilazapril + hidroclorotiazida in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAPO-CILAZAPRIL/HCTZAPOTEX INC
- SwitzerlandInhibace Plus
- CzechiaINHIBACE PLUSCHEPLAPHARM Arzneimittel GmbH, Greifswald
- PolandCazacombiKrka, d.d., Novo mesto
- GermanyDynorm PlusCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Inhibace Plus
- Belgium · Co-Inhibace
- Czechia · Inhibace Plus
- Germany · Dynorm Plus
- Greece · Vascace Plus
- Hungary · Inhibace Plus
- Italy · Inibace Plus, Initiss Plus
- Poland · Inhibace Plus
- Portugal · Cilazapril + Hidroclorotiazida Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/62d8f245-68dd-41b3-ba03-af05e5e63db1 GET /v1/drugs/62d8f245-68dd-41b3-ba03-af05e5e63db1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1569571743000,\"rev\":1734454861000}",
"nregistro": "58-181-03C",
"substance": "cilazapril + hidroclorotiazida"
}See everything about cilazapril + hidroclorotiazida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.